Skip to main content
Tech.euFundingExplorerBeta

Lucid Genomics

B2B software-as-a-service platform that offers 100% DNA analysis solutions for the healthcare and pharmaceutical sectors

Lucid Genomics has raised €1.3M across 1 funding round from 4 investors, most recently a round in Sep 2024. Based in Berlin, Germany; active in Healthtech. Data as of 28 Oct 2026.

Total raised
€1.3M
€1,300,000
Funding rounds
1
Investors
4
distinct backers
Active since
2024-09
latest 2024-09

Funding by year

EUR raised per year
Lucid Genomics — funding by year — interactive chart.
Data table
Lucid Genomics — funding by year
2024€1.3M

Signals

High confidence
Raise-next likelihood21
base rate 30% for Other
  • ▼ Past typical raise window
  • ▼ Low backer re-investment

Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

1 round
DateStageAmountInvestors
2024-09-03Other€1.3Manother.vc,BIF Partners,Caesar Ventures,MPF Accelerator ProgramView deal →

Similar companies

same sector or country

Global coverage: FundingData